National Eczema Association and topical calcineurin inhibitor labeling.
Cooper
Kevin
K
D000279:Administration, Cutaneous; D065095:Calcineurin Inhibitors; D017277:Drug Approval; D004348:Drug Labeling; D004485:Eczema / Q000188:drug therapy*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D065095:Calcineurin Inhibitors